Supreme Pharmaceuticals

Supreme Pharmaceuticals set to ink cannabis genetics supply deal

It has agreed in principle to supply a Canadian licensed producer with multiple premium cannabis cultivars, or specifically cultivated strains of cannabis

Cannabis farm.
The genetics business diversifies Supreme's revenue base

Supreme Pharmaceuticals Inc (CVE:SL) is set to ink a deal that will see it extend its previously announced diversification to encompass a business-to-business model.

It has agreed in principle to supply a Canadian licensed producer with multiple premium cannabis cultivars for production by the licensed producer, subject to obtaining applicable regulatory approvals, execution of definitive agreements and other customary closing conditions.

If all goes well, the transaction should complete within the next 60 days.

"Last month, we announced the commencement of our business-to-business sales model by entering into letters of intent for the sale of dried marijuana to five fully licensed Canadian licensed producers. Today marks the commencement of the second leg of our business: supply of high-quality cannabis genetics to other licensed producers,” said John Fowler, chief executive officer of Supreme.

“The genetics business diversifies our revenue while remaining committed to supporting the aggregate growth of the legal cannabis industry in Canada," Fowler added.

Shares in Supreme were unchanged on the news.

Quick facts: Supreme Pharmaceuticals

Price: £0.00

Market: CSE
Market Cap: £0.00

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

15 hours, 37 minutes ago

2 min read